Funded by a $230,979 grant, an Ohio University study tests metformin to prevent Clostridioides difficile in heart patients.
56% Increase in C. diff Due in Part to Improved Detection Hospitals that switched Clostridium difficile testing from nonmolecular to molecular methods recorded a 56 percent increase in recorded C.
An EMR-based alert helped reduce unnecessary orders for testing for Clostridioides difficile infection in hospitals, according to a study published in Infection Control & Hospital Epidemiology.
Arlington, Va. — June 27, 2024 — A new study published today in the American Journal of Infection Control (AJIC) describes the outcome of a new approach to testing for Clostridioides difficile (C.
A new study published today in the American Journal of Infection Control (AJIC) describes the outcome of a new approach to testing for Clostridioides difficile (C. diff) guided by the principles of ...
Hospitals across the country are being challenged by diagnosing a contagious and deadly superbug. A local lab has a solution to the illness affecting hundreds of thousands of Americans. Clostridium ...
BOULDER, CO, UNITED STATES, October 8, 2025 /EINPresswire.com/ -- Faex Health, a fast-growing digital health startup, today announced the release of its C. difficile ...
Great Basin Corporation Submits 510(K) Application to FDA for C. Difficile Molecular Diagnostic Test
SALT LAKE CITY--(BUSINESS WIRE)-- Great Basin Corporation, a privately held life sciences company developing sample-to-result molecular diagnostic solutions, today announced it has submitted a 510(k) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results